These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 10679246)

  • 21. Growth hormone regulates ternary complex factors and serum response factor associated with the c-fos serum response element.
    Liao J; Hodge C; Meyer D; Ho PS; Rosenspire K; Schwartz J
    J Biol Chem; 1997 Oct; 272(41):25951-8. PubMed ID: 9325329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defects of insulin and IGF-1 action at receptor and postreceptor level in a patient with type A syndrome of insulin resistance.
    Knebel B; Kellner S; Kotzka J; Siemeister G; Dreyer M; Streicher R; Schiller M; Rüdiger HW; Seemanova E; Krone W; Müller-Wieland D
    Biochem Biophys Res Commun; 1997 May; 234(3):626-30. PubMed ID: 9175764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia induces c-fos transcription via a mitogen-activated protein kinase-dependent pathway.
    Müller JM; Krauss B; Kaltschmidt C; Baeuerle PA; Rupec RA
    J Biol Chem; 1997 Sep; 272(37):23435-9. PubMed ID: 9287359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of apoptosis by Elk-1 and deltaElk-1 proteins.
    Shao N; Chai Y; Cui JQ; Wang N; Aysola K; Reddy ES; Rao VN
    Oncogene; 1998 Jul; 17(4):527-32. PubMed ID: 9696047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylation-dependent formation of a quaternary complex at the c-fos SRE.
    Gille H; Kortenjann M; Strahl T; Shaw PE
    Mol Cell Biol; 1996 Mar; 16(3):1094-102. PubMed ID: 8622654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of ternary complex factor Elk-1 by MAP kinases.
    Janknecht R; Ernst WH; Pingoud V; Nordheim A
    EMBO J; 1993 Dec; 12(13):5097-104. PubMed ID: 8262053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pim-1 kinase inhibits the activation of reporter gene expression in Elk-1 and c-Fos reporting systems but not the endogenous gene expression: an artifact of the reporter gene assay by transient co-transfection.
    Yan B; Wang H; Kon T; Li CY
    Braz J Med Biol Res; 2006 Feb; 39(2):169-76. PubMed ID: 16470303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mice deficient for the ets transcription factor elk-1 show normal immune responses and mildly impaired neuronal gene activation.
    Cesari F; Brecht S; Vintersten K; Vuong LG; Hofmann M; Klingel K; Schnorr JJ; Arsenian S; Schild H; Herdegen T; Wiebel FF; Nordheim A
    Mol Cell Biol; 2004 Jan; 24(1):294-305. PubMed ID: 14673163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotensin type 1 receptor-mediated activation of krox24, c-fos and Elk-1: preventing effect of the neurotensin antagonists SR 48692 and SR 142948.
    Portier M; Combes T; Gully D; Maffrand JP; Casellas P
    FEBS Lett; 1998 Jul; 432(1-2):88-93. PubMed ID: 9710257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ternary complex factors: prime nuclear targets for mitogen-activated protein kinases.
    Shaw PE; Saxton J
    Int J Biochem Cell Biol; 2003 Aug; 35(8):1210-26. PubMed ID: 12757758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A peptide-based synthetic transcription factor selectively down-regulates the proto-oncogene CFOS in tumour cells and inhibits proliferation.
    Chakraborty M; Roy S
    Chem Commun (Camb); 2016 Dec; 53(2):376-379. PubMed ID: 27935608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MAP kinase-mediated c-fos regulation relies on a histone acetylation relay switch.
    O'Donnell A; Yang SH; Sharrocks AD
    Mol Cell; 2008 Mar; 29(6):780-5. PubMed ID: 18374651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide analysis reveals PADI4 cooperates with Elk-1 to activate c-Fos expression in breast cancer cells.
    Zhang X; Gamble MJ; Stadler S; Cherrington BD; Causey CP; Thompson PR; Roberson MS; Kraus WL; Coonrod SA
    PLoS Genet; 2011 Jun; 7(6):e1002112. PubMed ID: 21655091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification, crystallization and preliminary X-ray crystallographic analysis of the ETS domain of human Ergp55 in complex with the cfos promoter DNA sequence.
    Gangwar SP; Meena SR; Saxena AK
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Nov; 68(Pt 11):1333-6. PubMed ID: 23143243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of PAK3 Signaling in Social Interaction Induced cFos Positive Cells Impairs Social Recognition Memory.
    Zhou S; Jia Z
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GnRH induces the c-Fos gene via phosphorylation of SRF by the calcium/calmodulin kinase II pathway.
    Ely HA; Mellon PL; Coss D
    Mol Endocrinol; 2011 Apr; 25(4):669-80. PubMed ID: 21292826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a postreceptor signaling defect that impairs cfos expression in cultured fibroblasts of a patient with insulin resistance.
    Knebel B; Kotzka J; Avci H; Schiller M; Brüning JC; Hafner M; Krone W; Müller-Wieland D
    Biochem Biophys Res Commun; 2000 Feb; 268(2):577-82. PubMed ID: 10679246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced phosphorylation of transcription factor Elk-1 in cultured fibroblasts of a patient with premature aging syndrome and insulin resistance.
    Knebel B; Avci H; Bullmann C; Kotzka J; Müller-Wieland D
    Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):94-101. PubMed ID: 15772901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells.
    Chai Y; Chipitsyna G; Cui J; Liao B; Liu S; Aysola K; Yezdani M; Reddy ES; Rao VN
    Oncogene; 2001 Mar; 20(11):1357-67. PubMed ID: 11313879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.